| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |